You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Type 2 Issues Articles
Popular Type 2 Issues Articles
Highly Recommended Type 2 Issues Articles
Send a link to this page to your friends and colleagues.
This press release is an announcement submitted by WelChol, and was not written by Diabetes Health.
In two recent studies, WelChol, a drug already approved for lowering LDL (bad) cholesterol was found to lower A1c's in patients with type 2 diabetes. The first study showed that WelChol, when added to insulin, lowered A1c's by an average of 0.5% compared to a placebo group.
In the second study, WelChol added to an oral antidiabetic therapy again resulted in mean A1c reductions of 0.5% compared to the placebo group.
As a result of these findings, the manufacturer has applied for approval to market their drug as a one-two punch for both cholesterol and type 2 diabetes. If approved, it will be the first drug to target both conditions.
* * *
Source: WelChol Press Release
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.